LFB Biomanufacturing is a contract development and manufacturing organisation (CDMO) specialising in the production of recombinant proteins and monoclonal antibodies for the biopharmaceutical industry. The company is recognised for its comprehensive capabilities in biomanufacturing, spanning from drug discovery to commercial production.

LFB Biomanufacturing offers end-to-end services, providing cell line development, process optimisation, and commercial-scale manufacturing. With over 25 years of experience, it is committed to supporting the development of therapeutic proteins, including monoclonal antibodies, for global healthcare needs.

Key Products and Services

• Cell line development and banking (CHO-S and proprietary EMABling® platform)
• Process development and scale-up
• GMP manufacturing of recombinant medicinal products
• Formulation development for monoclonal antibodies and complex proteins
• Bioassay development and analytical services

LFB Biomanufacturing’s dedication to quality, innovation, and regulatory compliance makes it a trusted partner for pharmaceutical companies looking to bring life-saving biologics to market.